Insight Molecular Diagnostics (IMDX) Net Income Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Net Income Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -9.74% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -27.15% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 12.89% |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -43.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.72% |
| Dec 31, 2025 | 29.91% |
| Sep 30, 2025 | 13.85% |
| Jun 30, 2025 | -62.27% |
| Mar 31, 2025 | 14.32% |
| Mar 31, 2024 | -212.00% |
| Mar 31, 2023 | 57.46% |
| Dec 31, 2022 | 7.65% |
| Sep 30, 2022 | 45.54% |
| Jun 30, 2022 | 33.90% |
| Mar 31, 2022 | -75.50% |
| Dec 31, 2021 | -438.57% |
| Sep 30, 2021 | -103.45% |
| Jun 30, 2021 | -51.68% |
| Mar 31, 2021 | 60.50% |
| Dec 31, 2020 | 16.68% |
| Sep 30, 2020 | -29.82% |
| Jun 30, 2020 | -28.52% |
| Mar 31, 2020 | -156.78% |
| Dec 31, 2019 | 66.77% |